[Inhibitors for protein tyrosine kinases, erbstatin, genistein and herbimycin A, induce differentiation of human neural tumor cell lines]
- PMID: 1668058
[Inhibitors for protein tyrosine kinases, erbstatin, genistein and herbimycin A, induce differentiation of human neural tumor cell lines]
Abstract
Recent reports suggest that protein phosphorylation is involved in neural differentiation. We have found that specific inhibitors of protein phosphorylation at tyrosine residues, Erbstatin, Genistein, Herbimycin A, effectively induce neural differentiation in a human neuroblastoma cell line SK-N-DZ and a human medulloblastoma cell line Med-3, as indicated by the marked increase in the number of neurites/cell and in the expression of neurofilaments (160 k) detected by immunohistochemical studies. Possible involvement of protein phosphorylation at tyrosine residues in the differentiation of neural tumor cells was stressed.
Similar articles
-
Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules.J Immunol. 1995 Jul 1;155(1):445-51. J Immunol. 1995. PMID: 7541425
-
Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line.Leuk Res. 1993 Oct;17(10):847-53. doi: 10.1016/0145-2126(93)90150-j. Leuk Res. 1993. PMID: 8412297
-
Induction of differentiation of human leukemia cells with a structurally altered c-abl (bcr/abl) gene by herbimycin A, an inhibitor of tyrosine kinase activity.Leukemia. 1992 Mar;6(3):229-31. Leukemia. 1992. PMID: 1564963 No abstract available.
-
[Inhibitors of protein-tyrosine kinases: pharmacological perspectives?].Pathol Biol (Paris). 1995 May;43(5):389-94. Pathol Biol (Paris). 1995. PMID: 8532375 Review. French. No abstract available.
-
Genistein as an inducer of tumor cell differentiation: possible mechanisms of action.Proc Soc Exp Biol Med. 1995 Jan;208(1):109-15. doi: 10.3181/00379727-208-43841. Proc Soc Exp Biol Med. 1995. PMID: 7892284 Review.
Cited by
-
Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification.Invest New Drugs. 2010 Dec;28(6):812-24. doi: 10.1007/s10637-009-9324-7. Epub 2009 Sep 24. Invest New Drugs. 2010. PMID: 19777160 Free PMC article.
-
Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.J Neurooncol. 2002 May;57(3):193-200. doi: 10.1023/a:1015765616484. J Neurooncol. 2002. PMID: 12125982
-
Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity.RSC Adv. 2018 Apr 16;8(25):14048-14055. doi: 10.1039/c8ra00744f. eCollection 2018 Apr 11. RSC Adv. 2018. PMID: 35539303 Free PMC article.
-
CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cells.Mol Oncol. 2012 Feb;6(1):48-61. doi: 10.1016/j.molonc.2011.11.004. Epub 2011 Nov 25. Mol Oncol. 2012. PMID: 22153617 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources